The Justice Department alleged that Mallinckrodt ARD LLC, started calculating and paying rebates as if Acthar was a new drug first marketed in 2013 after the Food and Drug Administration approved a new indication for its use in 2010. "U.S. Sues Mallinckrodt for Allegedly Underpaying Medicaid Rebates," on March 3, 2020, incorrectly referred to the agency as the federal drug administration.

(END) Dow Jones Newswires

June 14, 2021 14:26 ET (18:26 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.
Mallinckrodt () (USOTC:MNKKQ)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024 Click aqui para mais gráficos Mallinckrodt ().
Mallinckrodt () (USOTC:MNKKQ)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024 Click aqui para mais gráficos Mallinckrodt ().